When action movie star Chuck Norris earlier this month filed suit against firms involved in the distribution of gadolinium-based contrast agents, he put a human face on the gadolinium retention issue. MRI safety expert Dr. Emanuel Kanal of the University of Pittsburgh discusses the latest findings in what's known about gadolinium safety in this video.
Correction, Kanal Video 1 My MistakeVideo from RSNA 2017: Gadolinium retention debate takes center stage
Nov 28, 2017
Latest in Home
PET links brain receptor to emotional numbing in PTSD
August 25, 2025
CEM, DBT show promise for preoperative breast cancer staging
August 25, 2025
3D DEXA reveals lower bone density in diabetes patients
August 22, 2025